Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.
Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
Published

Chronic obstructive pulmonary disease – diagnosis and management ACG

Condition

Respiratory

Guidance type

ACG

6 December 2024

Published on 25 Sep 2018
Last Updated on 06 Dec 2024

This ACE Clinical Guideline (ACG) highlights the diagnostic approach for chronic obstructive pulmonary disease (COPD), including differential diagnosis with relevant conditions such as asthma. Diagnostic recommendations are complemented by a supplementary guide on how to interpret spirometry reports, as well as a list of spirometry sites in Singapore that are open to external referrals. The ACG also covers non-pharmacological and pharmacological management options for patients with stable COPD, with a focus on the importance of smoking cessation, and appropriate use of bronchodilators or inhaled corticosteroids.  

First published in 2018, guideline on COPD has been updated in 2024 to consolidate diagnosis and management recommendations in one ACG, incorporating the latest evidence where relevant. In December 2024, links have been added to the ACG for the new patient education aids on the use of inhalers in COPD and spirometry testing.

Download the ACG

Chronic obstructive pulmonary disease – diagnosis and management (Dec 2024) [PDF] (opens in new tab)

Or click the link below for the web version

Chronic obstructive pulmonary disease – diagnosis and management (Dec 2024) [WEB]

Request for a hardcopy

Click here (opens in new tab)

Registered doctors, pharmacists and nurses may claim 1 Continuing Medical Education (CME)/Continuing Professional Education (CPE) point under category 3A/ category V-B for reading each ACG.

ACG Recommendations

  1. Suspect chronic obstructive pulmonary disease (COPD) in any patient with at least one relevant symptom and risk factor.

  2. Diagnose COPD in patients with relevant symptoms and risk factors who have airflow obstruction detected via spirometry (post‐bronchodilator FEV1/FVC <0.7).

  3. Regularly assess symptoms and exacerbation risk for all patients with COPD.

  4. Explain the benefits of smoking cessation on COPD progression and strongly encourage those who smoke to quit.

  5. Start bronchodilator treatment, preferably a long-acting bronchodilator, for patients with infrequent or less intense symptoms and lower risk of exacerbation.

  6. Start dual bronchodilator therapy with long-acting muscarinic antagonist (LAMA) + long-acting beta2-agonist (LABA) for patients with frequent or intense COPD symptoms, or a higher risk of exacerbations.

  7. Consider triple therapy with LAMA + LABA + inhaled corticosteroid (ICS) for patients with frequent COPD exacerbations and eosinophilia.

  8. Assess inhaler technique and medication adherence at every visit and provide support to ensure optimal benefits from medications.

ACG references and supplementary guides

Feedback

Click here (opens in new tab)to give us feedback on this ACG.

Related ACGs

Asthma ─ optimising long-term management with inhaled corticosteroid (opens in new tab)

Other related resources